Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer

NCT05078190 ·Status: ACTIVE_NOT_RECRUITING

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

NCT06282796 ·Status: RECRUITING

Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients

NCT00806507 ·Status: COMPLETED

Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry

NCT06086132 ·Status: RECRUITING

Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer

NCT05803889 ·Status: TERMINATED

Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude

NCT05063643 ·Status: UNKNOWN

Chronic Toxicities Related to Treatment in Patients With Localized Cancer

NCT01993498 ·Status: RECRUITING ·Phase: NA

Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab

NCT04961307 ·Status: UNKNOWN

Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer

NCT06040593 ·Status: COMPLETED

Cardiac Toxicity in Medical Treatment of Breast Cancer

NCT02440620 ·Status: COMPLETED

CARdiac Function Evaluation in Breast Cancer Patients

NCT03266809 ·Status: COMPLETED

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

NCT03882580 ·Status: UNKNOWN

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study

NCT01246856 ·Status: UNKNOWN

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

NCT04568161 ·Status: COMPLETED ·Phase: NA

Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index

NCT05728268 ·Status: RECRUITING ·Phase: PHASE2

Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer

NCT03983538 ·Status: COMPLETED

CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

NCT04059003 ·Status: UNKNOWN

Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy

NCT05019365 ·Status: UNKNOWN

A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients

NCT03983382 ·Status: ACTIVE_NOT_RECRUITING

SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial

NCT00002900 ·Status: COMPLETED

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

NCT03939481 ·Status: ACTIVE_NOT_RECRUITING

Combination Chemotherapy in Treating Women With Breast Cancer

NCT00003519 ·Status: COMPLETED ·Phase: PHASE3

Early Detection of Heart Problems in Cancer Patients Receiving Chemotherapy

NCT04413487 ·Status: WITHDRAWN

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

NCT00436566 ·Status: COMPLETED ·Phase: PHASE2

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

NCT05036252 ·Status: ACTIVE_NOT_RECRUITING